Wednesday, September 5, 2012

Molecular Therapy - Table of Contents alert Volume 20 Issue 9


TABLE OF CONTENTS

Volume 20, Issue 9 (September 2012)

In this issue
Editorial
In This Issue
Research Highlights
Letter to the Editor
Commentaries
Original Articles
Abstracts

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Now indexed in PubMed Central - Submit your research Molecular Therapy-Nucleic Acids
Online. Open Access. High-Quality Research.

Molecular Therapy-Nucleic Acids is a peer-reviewed, fully open access, online journal; sibling journal to the well-established high impact journal, Molecular Therapy. The journal publishes high quality basic, translational, and clinical research and cutting edge reviews and commentaries targeted to the advances in oligonucleotide and gene-based therapies; and now fully indexed on PubMed Central.

Submit your research
TODAY!!
 

Editorial

Top

Differing Approaches to Experimental Therapeutics: Are We a World Apart?

Timothy P Cripe

Mol Ther 2012 20: 1649-1650; 10.1038/mt.2012.174

Full Text

In This Issue

Top

In This Issue

Mol Ther 2012 20: 1652; 10.1038/mt.2012.176

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2012 20: 1653; 10.1038/mt.2012.177

Full Text

Letter to the Editor

Top

Treatment of Chemotherapy-Refractory Cancer in the Advanced Therapy Access Program

Akseli Hemminki

Mol Ther 2012 20: 1654-1655; 10.1038/mt.2012.170

Full Text

Commentaries

Top

Athletes’ Use of Unproven Stem Cell Therapies: Adding to Inappropriate Media Hype?

Timothy Caulfield and Amy McGuire

Mol Ther 2012 20: 1656-1658; 10.1038/mt.2012.172

Full Text

A CRISPR Approach to Gene Targeting

Dana Carroll

Mol Ther 2012 20: 1658-1660; 10.1038/mt.2012.171

Full Text

All for One, One for All: New Combinatorial RNAi Therapies Combat Hepatitis C Virus Evolution

Dirk Grimm

Mol Ther 2012 20: 1661-1663; 10.1038/mt.2012.173

Full Text

Original Articles

Top

Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12

José I Quetglas, Juan Dubrot, Jaione Bezunartea, Miguel F Sanmamed, Sandra Hervas-Stubbs, Cristian Smerdou and Ignacio Melero

Mol Ther 2012 20: 1664-1675; advance online publication, June 26, 2012; 10.1038/mt.2012.56

Abstract | Full Text

Failure of Translation of Human Adenovirus mRNA in Murine Cancer Cells Can be Partially Overcome by L4-100K Expression In Vitro and In Vivo

Anna-Mary Young, Kyra M Archibald, Laura A Tookman, Alexander Pool, Kate Dudek, Carolyn Jones, Sarah L Williams, Katrina J Pirlo, Anne E Willis, Michelle Lockley and Iain A McNeish

Mol Ther 2012 20: 1676-1688; advance online publication, June 26, 2012; 10.1038/mt.2012.116

Abstract | Full Text

Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression

Omar D Perez, Christopher R Logg, Kei Hiraoka, Oscar Diago, Ryan Burnett, Akihito Inagaki, Dawn Jolson, Karin Amundson, Taylor Buckley, Dan Lohse, Amy Lin, Cindy Burrascano, Carlos Ibanez, Noriyuki Kasahara, Harry E Gruber and Douglas J Jolly

Mol Ther 2012 20: 1689-1698; advance online publication, May 1, 2012; 10.1038/mt.2012.83

Abstract | Full Text

Lentiviral Vectors Displaying Modified Measles Virus gp Overcome Pre-existing Immunity in In Vivo-like Transduction of Human T and B Cells

Camille Lévy, Fouzia Amirache, Caroline Costa, Cecilia Frecha, Claude P Muller, Hasan Kweder, Robin Buckland, François-Loïc Cosset and Els Verhoeyen

Mol Ther 2012 20: 1699-1712; advance online publication, May 22, 2012; 10.1038/mt.2012.96

Abstract | Full Text

Gene Transfer to the CNS Is Efficacious in Immune-primed Mice Harboring Physiologically Relevant Titers of Anti-AAV Antibodies

Christopher M Treleaven, Thomas J Tamsett, Jie Bu, Jonathan A Fidler, S Pablo Sardi, Gregory D Hurlbut, Lisa A Woodworth, Seng H Cheng, Marco A Passini, Lamya S Shihabuddin and James C Dodge

Mol Ther 2012 20: 1713-1723; advance online publication, June 26, 2012; 10.1038/mt.2012.114

Abstract | Full Text

Inhibition of Hepatitis C Virus Replication by Intracellular Delivery of Multiple siRNAs by Nanosomes

Partha K Chandra, Anup K Kundu, Sidhartha Hazari, Sruti Chandra, Lili Bao, Tara Ooms, Gilbert F Morris, Tong Wu, Tarun K Mandal and Srikanta Dash

Mol Ther 2012 20: 1724-1736; advance online publication, May 22, 2012; 10.1038/mt.2012.107

Abstract | Full Text

Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model

David A Suhy, Shih-Chu Kao, Tin Mao, Laurence Whiteley, Hubert Denise, Bernard Souberbielle, Andrew D Burdick, Kyle Hayes, J Fraser Wright, Helen Lavender, Peter Roelvink, Alexander Kolykhalov, Kevin Brady, Sterghios A Moschos, Bernd Hauck, Olga Zelenaia, Shangzhen Zhou, Curt Scribner, Katherine A High, Sara H Renison and Romu Corbau

Mol Ther 2012 20: 1737-1749; advance online publication, June 26, 2012; 10.1038/mt.2012.119

Abstract | Full Text

Secondary Sphere Formation Enhances the Functionality of Cardiac Progenitor Cells

Hyun-Jai Cho, Ho-Jae Lee, Seock-Won Youn, Seok-Jin Koh, Joo-Yun Won, Yeon-Ju Chung, Hyun-Ju Cho, Chang-Hwan Yoon, Sae-Won Lee, Eun Ju Lee, Yoo-Wook Kwon, Hae-Young Lee, Sang Hun Lee, Won-Kyung Ho, Young-Bae Park and Hyo-Soo Kim

Mol Ther 2012 20: 1750-1766; advance online publication, June 19, 2012; 10.1038/mt.2012.109

Abstract | Full Text

Inducible IL10+ Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization

Jeremy Hsieh, Patrick Williams, Moutih Rafei, Elena Birman, Jessica Cuerquis, Shala Yuan, JianHui Wu and Jacques Galipeau

Mol Ther 2012 20: 1767-1777; advance online publication, July 3, 2012; 10.1038/mt.2012.127

Abstract | Full Text

Enforced IL-10 Expression Confers Type 1 Regulatory T Cell (Tr1) Phenotype and Function to Human CD4+ T Cells

Grazia Andolfi, Georgia Fousteri, Maura Rossetti, Chiara F Magnani, Tatiana Jofra, Grazia Locafaro, Attilio Bondanza, Silvia Gregori and Maria-Grazia Roncarolo

Mol Ther 2012 20: 1778-1790; advance online publication, June 12, 2012; 10.1038/mt.2012.71

Abstract | Full Text

Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine

Chantal G Lemay, Julia L Rintoul, Agnieszka Kus, Jennifer M Paterson, Vanessa Garcia, Theresa J Falls, Lisa Ferreira, Byram W Bridle, David P Conrad, Vera A Tang, Jean-Simon Diallo, Rozanne Arulanandam, Fabrice Le Boeuf, Kenneth Garson, Barbara C Vanderhyden, David F Stojdl, Brian D Lichty, Harold L Atkins, Kelley A Parato, John C Bell and Rebecca C Auer

Mol Ther 2012 20: 1791-1799; advance online publication, July 3, 2012; 10.1038/mt.2012.128

Abstract | Full Text

PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral Vaccines

Bingbing Dai, Liang Xiao, Paul D Bryson, Jinxu Fang and Pin Wang

Mol Ther 2012 20: 1800-1809; advance online publication, May 15, 2012; 10.1038/mt.2012.98

Abstract | Full Text

HSV-1 Amplicon Vectors Launch the Production of Heterologous Rotavirus-like Particles and Induce Rotavirus-specific Immune Responses in Mice

Andrea S Laimbacher, Laura E Esteban, Alejandro A Castello, Juan C Abdusetir Cerfoglio, Marcelo H Argüelles, Graciela Glikmann, Alejandra D'Antuono, Nora Mattion, Mabel Berois, Juan Arbiza, Monika Hilbe, Elisabeth M Schraner, Michael Seyffert, Christiane Dresch, Alberto L Epstein, Mathias Ackermann and Cornel Fraefel

Mol Ther 2012 20: 1810-1820; advance online publication, June 19, 2012; 10.1038/mt.2012.108

Abstract | Full Text

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

Otto Hemminki, Iulia Diaconu, Vincenzo Cerullo, Saila K Pesonen, Anna Kanerva, Timo Joensuu, Kalevi Kairemo, Leena Laasonen, Kaarina Partanen, Lotta Kangasniemi, Andre Lieber, Sari Pesonen and Akseli Hemminki

Mol Ther 2012 20: 1821-1830; advance online publication, August 7, 2012; 10.1038/mt.2012.115

Abstract | Full Text

Abstracts

Top

Late Abstracts: Presented at the American Society of Gene & Cell Therapy’s 15th Annual Meeting, May 16–19, 2012, Philadelphia, Pennsylvania

Mol Ther 2012 20: e1-e63; 10.1038/mt.2012.179

Full Text

Molecular Therapy-Nucleic Acids
Online.Open Access.High-Quality Research.

Molecular Therapy-Nucleic Acids is a peer-reviewed, fully open access, online journal. Sibling journal to the well-established high impact journal, Molecular Therapy. The journal publishes high quality basic, translational, and clinical research and cutting edge reviews and commentaries targeted to the advances in oligonucleotide- and gene-based therapies.
Submit your research TODAY!!
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: